Identification of an Exosome-Related Signature for Predicting Prognosis, Immunotherapy Efficacy, and Tumor Microenvironment in Lung Adenocarcinoma

<div>Univariate and multivariate Cox analyses for the signature-based risk score and other clinical features. (a) A univariate Cox regression analysis validated the signature-based risk score as a predictive factor for the TCGA-LUAD and GSE72094 cohorts. (b) A multivariable Cox regression analysis validated the signature-based risk score as an independent predictive factor for the training cohort and two external validation cohorts.</div>

Journal of Oncology

fig4

Figure 4

Figure 4: Identification of an Exosome-Related Signature for Predicting Prognosis, Immunotherapy Efficacy, and Tumor Microenvironment in Lung Adenocarcinoma 

Figure 4 | Identification of an Exosome-Related Signature for Predicting Prognosis, Immunotherapy Efficacy, and Tumor Microenvironment in Lung Adenocarcinoma 